Robert Hallivis, DPM
Foot & Ankle Surgery · Fairfax, VANPI 1215938006
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 40.7% of the total. 2025 is the largest year on record at $9,045, 6.8 times the $1,323 reported in 2019.
Across 149 payments — averaging $137.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$8K
- Arthrex$8K
- Stryker$1K
- Smith+Nephew$806
- Arteriocyte Medical Systems, Inc.$243
- Organogenesis Inc.$203
- plus $2K from 28 others
What the payments were for
- Consulting fees$7,57237%
- Speaking & faculty fees$7,50037%
- Travel & lodging$9425%
- Food & beverage$4,50222%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 12 | $8,343 |
| Arthrex | 3 | $7,519 |
| Stryker(2 entities) | 19 | $1,424 |
| Smith+Nephew | 30 | $806 |
| Arteriocyte Medical Systems, Inc. | 1 | $243 |
| Organogenesis Inc. | 6 | $203 |
| Integra Lifesciences Corporation | 8 | $176 |
| Convatec Inc. | 2 | $167 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $162 |
| Biocomposites Inc | 2 | $159 |
| Supreme Orthopedic Systems, LLC | 6 | $142 |
| Paragon 28, Inc. | 1 | $127 |
| Triad Life Sciences Inc. | 2 | $122 |
| Johnson & Johnson | 8 | $121 |
| Fusion Orthopedics USA, LLC | 1 | $105 |
| Amgen(2 entities) | 5 | $101 |
| Kerecis Limited | 4 | $88 |
| Paratek Pharmaceuticals, Inc. | 4 | $60 |
| Sandoz | 4 | $59 |
| Ossio Inc | 2 | $55 |
| Orthofix Medical, Inc. | 3 | $52 |
| Melinta Therapeutics, LLC | 3 | $48 |
| Novastep Inc. | 1 | $44 |
| Medtronic | 2 | $32 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Linvatec Corporation | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Medartis Inc. | 1 | $16 |
| Reapplix Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Hartmann USA, Inc. | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$7,572
- MIS Instrumentation$640
- TMC NANOPLASTY SYSTEM$485
- InnovaMatrix AC$261
- FIXOS$248
- Magellan$243
- TMC SPEEDMTP$181
- Stravix$146
- Grafix$146
- Additive Orthopedics$127
- PuraPly$115
- Stimulan$111
- VARIAX$103
- T2$103
- ALLOGRAFT$103
How this compares
$20,516 in reported general payments places this provider in the 85th percentile of 260 foot & ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 44 | $43,545 |
| Tavaborole | 12 | $4,460 |
| Fluocinonide | 17 | $842 |
| Ciclopirox | 17 | $539 |
| Mupirocin | 54 | $511 |
| CiclopiroxCiclopirox Olamine | 26 | $312 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $136 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $117 |
| Cefadroxil | 23 | $113 |
| Doxycycline Hyclate | 13 | $90 |
| Methylprednisolone | 18 | $82 |
| Meloxicam | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $162 | $43,54544 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 260 foot & ankle surgery providers in Virginia.
Other foot & ankle surgery in Fairfax
- Jugal DhariaFairfax$309K
- Zakee ShabazzFairfax$15K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
- Bradley LevittVirginia Beach$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.